目次
Part I: Viral Carcinogenesis
Analysis of Viral Entry and Cell Fusion Mediated by Human T-cell Leukemia VirusType I Envelope
Glycoproteins
Transgenic Mouse Model for Viral Hepatocarcinogenesis
Part II: Gene Therapy for Cancer
Gene Therapy for Hepatocellular Carcinoma
Mutations of Tumor Suppressor Gene P53 in Hepatocellular Carcinoma and In Vivo and In Vitro
Efficacy of P53 Gene Therapy
Apoptotic Signal Induced by TNF Receptor
Part III: Leukemogenesis
MTG8 Protooncogene and Leukemia
Role of AML1 in Normal and Leukemic Hematopoiesis
Part IV: Differentiation Therapy for Hematologic Malignancies
Molecular Mechanisms of Retinoid-Resistance in Acute Promyelocytic Leukemia(APL) and Recent
Advance of Differentiation-Inducing Therapy for Leukemia
Clinical and Experimental Studies on Arsenicals in Treatment of Hematopoietic Malignancies
Part V: Signal Transduction of Hematopoietic and Immune Cells
Signal Transduction of IL-4 and IL-13:Its Correlation with the Pathogenesis of Allergic Diseases
Involvement of CrkL/C3G and Rap1 in Signaling from the Erythropoietin Receptor
Critical Role of TIE2-Angiopoietin Signals in the Development of Hematopoietic Stem Cells
Part VI: Signal Transduction and Cancer
Regulation of Cell Fate by Cross-Talk between Stats and Smads
TGF- Signaling and Cancer
Part VII: New Aspect of Cancer Therapy
Farnesyltransferase Inhibitors as Potential Anti-Cancer Agents
Angiogenesis Inhibition Induces Tumor Dormancy
